Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 701–800 of 1,008
Alternative processing of the amyloid precursor protein family by rhomboid protease RHBDL4.
Paschkowsky, S., Hamzé, M., Oestereich, F., & Munter, L. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753582 · Cited by 58
“Then, in a second step, the remaining membrane-bound stubs are processed by -secretase (11).”
BackgroundMetabolic disorder in Alzheimer’s disease
Poddar, M. K., Banerjee, S., Chakraborty, A., & Dutta, D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00673-z · Cited by 61
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 62
Sherva, R., Baldwin, C. T., Inzelberg, R., Vardarajan, B., Cupples, L. A., Lunetta, K., Bowirrat, A., Naj, A., Pericak-Vance, M., Friedland, R. P., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100714 · Cited by 56
Hiraoka, Y., Ohno, M., Yoshida, K., Okawa, K., Tomimoto, H., Kita, T., & Nishi, E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04685.x · Cited by 68
Dobrowolska, J. A., Kasten, T., Huang, Y., Benzinger, T. L. S., Sigurdson, W., Ovod, V., Morris, J. C., & Bateman, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089998 · Cited by 55
“Although the pathophysiology of this disease is incompletely understood, the study of brain and cerebrospinal fluid (CSF) proteins, such as amyloid-b (Ab) and tau, have provided insight into AD molecular pathophysiology [2–6].”
BackgroundCutting Proteins within Lipid Bilayers: Rhomboid Structure and Mechanism
Lemberg, M. K., & Freeman, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.12.003 · Cited by 66
McElroy, B., Powell, J. C., & McCarthy, J. V. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.062 · Cited by 66
Presenilin/γ‐secretase activity regulates protein clearance from the endocytic recycling compartment
Zhang, M., Haapasalo, A., Kim, D. Y., Ingano, L. A. M., Pettingell, W. H., Kovacs, D. M., Zhang, M., Haapasalo, A., Kim, D. Y., Ingano, L. A. M., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5531fje · Cited by 57
Genetics of Early-Onset Alzheimer Dementia
Rademakers, R., Cruts, M., & Van Broeckhoven, C. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.39 · Cited by 57
“Because embryonic lethality precludes further analysis of PSEN1 on APP metabolism in vivo, brain cultures were derived from PSEN1 null-embryo’s[157].”
BackgroundTransgenic mouse models of neurodegenerative disease: Opportunities for therapeutic development
Jankowsky, J. L., Savonenko, A. V., Schilling, G., Wang, J., Xu, G. M., & Borchelt, D. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0073-7 · Cited by 63
γ-Secretase: never more enigmatic
Sisodia, S. S., Annaert, W. G., Kim, S., & Strooper, B. D. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01987-1 · Cited by 64
Self-citationAvci, D., Fuchs, S., Schrul, B., Fukumori, A., Breker, M., Frumkin, I., Chen, C., Biniossek, M. L., Kremmer, E., Schilling, O., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.012 · Cited by 57
“…of aspartyl proteases has been intensively studied, as its founding member, presenilin, forms the active subunit of the g-secretase complex (De Strooper et al., 1998; Steiner et al., 2000; Wolfe et al., 1999), mutations in which underlie familial Alzheimer’s disease (Levy-Lahad et al., 1995;…”
BackgroundMori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.762658 · Cited by 58
Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
Galla, L., Redolfi, N., Pozzan, T., Pizzo, P., & Greotti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030770 · Cited by 63
Elzinga, B. M., Twomey, C., Powell, J. C., Harte, F., & McCarthy, J. V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m803108200 · Cited by 57
Humanin and the Receptors for Humanin
Matsuoka, M., & Hashimoto, Y. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8090-z · Cited by 60
Subcellular localization of presenilins: association with a unique membrane pool in cultured cells
Kim, S.-H., Lah, J. J., Thinakaran, G., Levey, A., & Sisodia, S. S. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0280 · Cited by 45
Webster, N. J., Green, K. N., Peers, C., & Vaughan, P. F. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01236.x · Cited by 56
“Both PS-1 and PS-2 are cleaved by caspase-3 during apoptosis (Kim et al. 1997; Loetscher et al. 1997; Vito et al. 1997) which, given the role of these proteins in APP processing (De Strooper et al. 1998), suggests an additional mechanism by which apoptosis could regulate production of Ab.”
BackgroundTau is central in the genetic Alzheimer–frontotemporal dementia spectrum
Dermaut, B., Kumar‐Singh, S., Rademakers, R., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.09.005 · Cited by 60
Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1
Dewachter, I., Ris, L., Croes, S., Borghgraef, P., Devijver, H., Voets, T., Nilius, B., Godaux, E., & LEUVEN, F. V. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.019 · Cited by 59
Characterization of Drosophila Presenilin and its colocalization with Notch during development
Ye, Y., & Fortini, M. E. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00169-5 · Cited by 53
Presenilin‐1 Exists in Both Pre‐ and Post‐Golgi Compartments and Recycles Via COPI‐Coated Membranes
Réchards, M., Xia, W., Oorschot, V. M. J., Selkoe, D. J., & Klumperman, J. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.t01-1-00114.x · Cited by 55
Duclot, F., Meffre, J., Jacquet, C., Gongora, C., & Maurice, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.055 · Cited by 58
“Indeed, PS1 deficiency drastically reduced A production (De Strooper et al., 1998), while PS2 deficiency failed to affect A levels (Herreman et al., 1999).”
Wang, C., Shou, Y., Pan, J., Du, Y., Liu, C., & Wang, H. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1416942 · Cited by 50
Mouse Models of Alzheimer's Disease: A Quest for Plaques
Richardson, J. A., & Burns, D. K. (2002) · ILAR Journal · doi:10.1093/ilar.43.2.89 · Cited by 53
Lleó, A., Berezovska, O., Ramdya, P., Fukumoto, H., Raju, S., Shah, T., & Hyman, B. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308480200 · Cited by 56
Redox Labile Site in a Zn4 Cluster of Cu4,Zn4−Metallothionein-3
Roschitzki, B., & Vašák, M. (2003) · Biochemistry · doi:10.1021/bi034816z · Cited by 55
Presenilin mutations line up along transmembrane α-helices
Hardy, J., & Crook, R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01910-3 · Cited by 59
Alzheimer Disease: Mouse Models Pave the Way for Therapeutic Opportunities
Emilien, G., Maloteaux, J.-M., Beyreuther, K., & Masters, C. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.176 · Cited by 55
Presenilin/γ-Secretase Activity Is Located in Acidic Compartments of Live Neurons
Maesako, M., Houser, M. C. Q., Turchyna, Y., Wolfe, M. S., & Berezovska, O. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1698-21.2021 · Cited by 55
Intramembrane Proteolysis in Regulated Protein Trafficking
Lemberg, M. K. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01219.x · Cited by 61
“Within the endocytic compartments and the trans-Golgi network, highest rate of APP shedding by β-secretase is observed (94).”
BackgroundInfluentialJayne, T., Newman, M., Verdile, G., Sutherland, G. T., Münch, G. W., Musgrave, I., Nik, S. H. M., & Lardelli, M. T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151186 · Cited by 56
“While the effects of fAD mutations on A production have been seen to be variable (for example, see summaries in [18, 19]), a consistent characteristic is a shift in the ratio of longer versus shorter forms of A and this is thought to favor the formation of purportedly toxic aggregates [19, 20].”
BackgroundPresenilin 2-Dependent Maintenance of Mitochondrial Oxidative Capacity and Morphology
Contino, S., Porporato, P. E., Bird, M., Marinangeli, C., Opsomer, R., Sonveaux, P., Bontemps, F., Dewachter, I., Octave, J.-N., Bertrand, L., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00796 · Cited by 47
“Over the two last decades, the seminal observation identifying PS1 as the catalytic core of the γ-secretase (De Strooper et al., 1998; Kimberly et al., 2003) launched a considerable research effort aimed at understanding the exact role of PSs in γ-secretase activity and Aβ production.”
BackgroundA technical KO of amyloid-β peptide
Haass, C., & Selkoe, D. J. (1998) · Nature · doi:10.1038/34800 · Cited by 63
Tau acts as a mediator forAlzheimer's disease‐related synaptic deficits
Liao, D., Miller, E. C., & Teravskis, P. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12504 · Cited by 53
“3, Pathway 2, blue arrows; DeStrooper et al., 1998; Ho & Shen, 2011; Endres & Reinhradt, 2013; Fonseca et al., 2013; McBrayer & Nixon, 2013; Shen, 2013).”
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease
D'Onofrio, G., Panza, F., Frisardi, V., Solfrizzi, V., Imbimbo, B. P., Paroni, G., Cascavilla, L., Seripa, D., & Pilotto, A. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.645534 · Cited by 50
“More than 90 type I integral membrane proteins have been shown to be cleaved by g-secretase, some of them with critical cellular functions [23-25], since the initial studies that demonstrated that PS-1-dependent g-secretase is essential for the processing of APP and the Notch receptor [26,84].”
BackgroundDerocq, D., Prébois, C., Beaujouin, M., Laurent‐Matha, V., Pattingre, S., Smith, G. K., & Liaudet‐Coopman, E. (2011) · Oncogene · doi:10.1038/onc.2011.501 · Cited by 55
Xia, W., Ostaszewski, B. L., Kimberly, W. T., Rahmati, T., Moore, C. L., Wolfe, M. S., & Selkoe, D. J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0322 · Cited by 51
“Deleting the PS1 gene in mice sharply inhibits Aß production and concomitantly increases the C99 and C83 substrates of g-secretase (De Strooper et al., 1998).”
BackgroundThe Value of Transgenic Models for the Study of Neurodegenerative Diseases
PRICE, D. L., WONG, P. C., MARKOWSKA, A. L., LEE, M. K., THINAKAREN, G., CLEVELAND, D. W., SISODIA, S. S., & BORCHELT, D. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06920.x · Cited by 53
Genetic studies in Alzheimer's disease
Tang, Y.-P., & Gershon, E. S. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.1/yptang · Cited by 48
“Indeed, compelling evidence has emerged to support a role for PS1 and PS2 in the γ-secretase proteolysis of APP, Notch (a transmembrane protein essential for neurogenesis), and other substrates.(105,107,109,111-116) For example, PS1 facilitates the proteolysis of APP C-terminal fragments by α- and β-secretase,(106,109…”
BackgroundSubstrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
Uemura, K., Farner, K. C., Hashimoto, T., Nasser-Ghodsi, N., Wolfe, M. S., Koo, E. H., Hyman, B. T., & Berezovska, O. (2010) · Nature Communications · doi:10.1038/ncomms1129 · Cited by 49
The biogenesis and biology of amyloid β oligomers in the brain
Ashe, K. H. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12084 · Cited by 54
Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application
Pietrzik, C. U., & Behl, C. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00435.x · Cited by 61
“Accordingly, a genetic knockout of PS1 resulted in a severely reduced Ab generation (De Strooper et al. 1998).”
BackgroundInactivation of presenilins causes pre‐synaptic impairment prior to post‐synaptic dysfunction
Zhang, D., Zhang, C., Ho, A., Kirkwood, A., Südhof, T. C., & Shen, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07011.x · Cited by 49
“…Aph1, Pen2 and Nicastrin, are integral components of a multiprotein protease complex, termed c-secretase, which is responsible for the intramembranous cleavage of type I transmembrane proteins, such as the amyloid precursor protein and Notch receptors (De Strooper et al. 1998, 1999; Fortini 2002).”
BackgroundHaapasalo, A., Kim, D. Y., Carey, B. W., Turunen, M. K., Pettingell, W. H., & Kovacs, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611324200 · Cited by 52
Pathogenic mechanisms in Alzheimer's disease
Pastorino, L., & Lu, K. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.078 · Cited by 60
Iwata, H., Tomita, T., Maruyama, K., & Iwatsubo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007989200 · Cited by 52
Presenilin Affects Arm/β-Catenin Localization and Function in Drosophila
Noll, E., Medina, M., Hartley, D. M., Zhou, J., Perrimon, N., & Kosik, K. S. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9925 · Cited by 59
Presenilins and the intramembrane proteolysis of proteins: facts and fiction
Strooper, B. D., & Annaert, W. G. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-e221 · Cited by 57
Self-citationMori, T., Koyama, N., Segawa, T., Maeda, M., Maruyama, N., Kinoshita, N., Hou, H., Tan, J., & Town, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568212 · Cited by 49
Structure and mechanism of intramembrane protease
Ha, Y. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.11.006 · Cited by 52
Unraveling the complexity of γ-secretase
Wolfe, M. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.01.005 · Cited by 55
“However, because it bore no resemblance to any known protease, presenilin was suggested as likely a regulator of γ-secretase activity [49], analogous to an activating factor involved in transmembrane processing of the sterol regulatory element binding protein [52].”
BackgroundTESCO, G., & TANZI, R. E. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06927.x · Cited by 50
Strooper, B. D., & Woodgett, J. R. (2003) · Nature · doi:10.1038/423392a · Cited by 62
Strooper, B. D. (2000) · Nature · doi:10.1038/35015193 · Cited by 57
Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13065 · Cited by 50
Müller, M., Cheung, K., & Foskett, J. K. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3421 · Cited by 55
“Mutant PS are believed to affect APP processing by either enhancing the total production of Ab or the relative proportion of the more amyloidogenic Ab-42 form (77).”
BackgroundInfluentialHuang, X., Wang, J., Chen, X., Liu, P., Wang, S., Song, F., Zhang, Z., Zhu, F., Huang, X., Liu, J., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00199 · Cited by 50
“Further, Xn suppressed the levels of total APP, BACE1 that are responsible for N-terminal cleavage for production of Aβ (Vassar et al., 1999) and PS1 that is responsible for C-terminal cleavage for production of Aβ (De Strooper et al., 1998).”
BackgroundPetit, D., Hitzenberger, M., Lismont, S., Zoltowska, K. M., Ryan, N. S., Mercken, M., Bischoff, F., Zacharias, M., & Chávez‐Gutiérrez, L. (2019) · The EMBO Journal · doi:10.15252/embj.2019101494 · Cited by 50
“PSEN bears the catalytic center of the enzyme (De Strooper et al , 1998; Steiner et al , 1999; Wolfe et al , 1999; Ahn et al , 2010), while the other “non-catalytic” subunits of the protease are required for the complex assembly, activation, structural stability/turnover, and trafficking…”
Substrate recognition and processing by γ-secretase
Wolfe, M. S. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.07.004 · Cited by 53
Lauritzen, I., Bécot, A., Bourgeois, A., Pardossi-Piquard, R., Biferi, M.-G., Barkats, M., & Checler, F. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0176-6 · Cited by 47
Developing Preventive Therapies for Chronic Diseases: Lessons Learned from Alzheimer's Disease
Selkoe, D. J. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00370.x · Cited by 50
Localization of a Fibrillar Amyloid β-Protein Binding Domain on Its Precursor
Van Nostrand, W. E., Melchor, J. P., Keane, D. M., Saporito-Irwin, S. M., Romanov, G., Davis, J., & Xu, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204676200 · Cited by 49
Closing in on the Amyloid Cascade
Doms, R. W., & Huse, J. T. (2000) · Molecular Neurobiology · doi:10.1385/mn:22:1-3:081 · Cited by 66
“Cells derived from mice deficient in the presenilins do not produce detectable quantities of Aβ and accumulate APP C-terminal fragments (114,136,137), implying a direct link between the presenilins and γ-secretase.”
BackgroundSzapacs, M. E., Numis, A. L., & Andrews, A. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.010 · Cited by 49
“Specific mutations in these genes lead to altered proteolytic processing of APP with missense mutations in the presenilins affecting γ– secretase, an enzyme that cleaves APP at the C-terminus (De Strooper, 1998; Wolfe, 1999).”
BackgroundPetralla, S., Panayotova, M., Franchina, E., Fricker, G., & Puris, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070948 · Cited by 49
Acevedo, K. M., Opazo, C. M., Norrish, D., Challis, L. M., Li, Q.-X., White, A. R., Bush, A. I., & Camakaris, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538710 · Cited by 48
“Only a small fraction of APP is cleaved at the cell surface with the remainder internalized to an early endosome compartment where -secretase and -secretase cleavage occurs to produce sAPP- and A peptides (68, 69).”
BackgroundRelease of a membrane-bound death domain by γ-secretase processing of the p75NTR homolog NRADD
Gowrishankar, K., Zeidler, M. G., & Vincenz, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01263 · Cited by 55
“Presenilins (PSs), a component of the γ-secretase, are I-CLiPs that were initially shown to cleave APP and Notch (De Strooper et al., 1999; De Strooper et al., 1998).”
BackgroundSampling the membrane: function of rhomboid-family proteins
Lemberg, M. K. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.01.002 · Cited by 54
Drosophila Signal Peptide Peptidase Is an Essential Protease for Larval Development
Casso, D. J., Tanda, S., Biehs, B., Martoglio, B., & Kornberg, T. B. (2005) · Genetics · doi:10.1534/genetics.104.039933 · Cited by 52
“How-et al. 1996; De Strooper et al. 1998; Kimberly et al. ever, the orientation of the SPP active site is apparently2001).”
BackgroundLoss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease
Somavarapu, A. K., & Kepp, K. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13535 · Cited by 53
Cui, Y., Huang, M., He, Y., Zhang, S., & Luo, Y. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.057 · Cited by 53
“Mutations associated with early-onset familial forms of AD (FAD) are found in the genes of APP, as well as the major components of -secretase, including presenilin 1 (PS1).(5,6) These FAD mutations increase the generation of A peptides and the relative proportion of the form A 42.”
BackgroundGhersi, E., Noviello, C., & D'Adamio, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405329200 · Cited by 46
Normal brain development in PS1 hypomorphic mice with markedly reduced γ-secretase cleavage of βAPP
Rozmahel, R. F., Huang, J., Chen, F., Liang, Y., Nguyen, V., Ikeda, M., Lévesque, G., Yu, G., Nishimura, M., Mathews, P. M., et al. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00267-6 · Cited by 51
Dysregulation of calcium in Alzheimer's disease
Brzyska, M., & Elbaum, D. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1465 · Cited by 50
“Neurons from PS1 knockout mice show normal – and –secretase activity but absent –secretase activity for human APP, suggesting that PS1 may regulate –secretase (De Strooper et al. 1998).”
BackgroundEnvironment enrichment rescues the neurodegenerative phenotypes in presenilins‐deficient mice
Dong, S., Li, C., Wu, P., Tsien, J. Z., & Hu, Y. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05641.x · Cited by 51
“Presenilin 1 (PS1) is an essential component of a multiprotein protease complex, termed c-secretase, which is responsible for the intramembranous cleavage of the amyloid precursor protein to produce b amyloid (Ab; De Strooper et al., 1998).”
BackgroundBretou, M., Sannerud, R., Escamilla-Ayala, A., Leroy, T., Vrancx, C., Van Acker, Z. P., Perdok, A., Vermeire, W., Vorsters, I., Van Keymolen, S., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.030 · Cited by 51
Self-citationStructure, mechanism and inhibition of γ-secretase and presenilin-like proteases
Wolfe, M. S. (2010) · Biological Chemistry · doi:10.1515/bc.2010.086 · Cited by 56
“(2) Knockout of presenilin genes eliminates g-secretase cleavage of APP (De Strooper et al., 1998; Herreman et al., 2000; Zhang et al., 2000).”
Powell, J. C., Twomey, C., Jain, R., & McCarthy, J. V. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05763.x · Cited by 53
Toglia, P. T., Cheung, K., Mak, D. D., & Ullah, G. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.02.013 · Cited by 49
“Dragicevic et al. [14] studied the effects of PS and APP mutations in multiple regions of the mice’s brain including cortical, hippocampal, stratal, and amygdalae.”
InfluentialMouse models of Alzheimer's disease: The long and filamentous road
Phinney, A. L., Horne, P., Yang, J., Janus, C., Bergeron, C., & Westaway, D. (2003) · Neurological Research · doi:10.1179/016164103101202020 · Cited by 46
APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity
Marlow, L. A., Canet, R. M., Haugabook, S. J., Hardy, J., Lahiri, D. K., & Sambamurti, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00797-6 · Cited by 49
Melchor, J. P., & Van Nostrand, W. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9782 · Cited by 48
The Glu318Gly Substitution in Presenilin 1 Is Not Causally Related to Alzheimer Disease
Dermaut, B., Cruts, M., Slooter, A. J. C., Gestel, S. V., Jonghe, C. D., Vanderstichele, H., Vanmechelen, E., Breteler, M. M. B., Hofman, A., van Duijn, C. M., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302200 · Cited by 53
Self-citationChasing genes in Alzheimer?s and Parkinson?s disease
Bertoli‐Avella, A. M., Oostra, B. A., & Heutink, P. (2004) · Human Genetics · doi:10.1007/s00439-004-1097-7 · Cited by 53
Clinical, biological, and imaging features of monogenic Alzheimer’s disease
Pilotto, A., Padovani, A., & Borroni, B. (2013) · BioMed Research International · doi:10.1155/2013/689591 · Cited by 47
“Also the relative contribution of PSEN1, PSEN2, and APP mutations to early onset Alzheimer’s Disease (EOAD) is the subject of considerable controversy, and mutation frequency is highly dependent upon the studied population [12–15].”
BackgroundFronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 49
Molecular mechanism of substrate recognition and cleavage by human γ-secretase
Guo, X., Li, H., Yan, C., Lei, J., Zhou, R., & Shi, Y. (2024) · Science · doi:10.1126/science.adn5820 · Cited by 50
Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH
Dang, S., Wu, S., Wang, J., Li, H., Huang, M., He, W., Li, Y., Wong, C. C. L., & Shi, Y. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502150112 · Cited by 47
“A precursor protein (APP) is initially cleaved by β-secretase in the extracellular space, producing a membrane-tethered, 99-residue carboxyl-terminal fragment known as APP C99 (1).”
BackgroundToward the structure of presenilin/γ-secretase and presenilin homologs
Wolfe, M. S. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.04.015 · Cited by 51
Chhibber‐Goel, J., Coleman-Vaughan, C., Agrawal, V., Sawhney, N., Hickey, E., Powell, J. C., & McCarthy, J. V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679076 · Cited by 47
“The presenilin proteins (PS1 and PS2) are the catalytic subunit of the -secretase complex (44, 45), and genetic inactivation of PS1 results in complete loss of -secretase activity (46, 47).”
BackgroundActivity-dependent regulation of β-catenin via ε-cleavage of N-cadherin
Uemura, K., Kihara, T., Kuzuya, A., Okawa, K., Nishimoto, T., Bito, H., Ninomiya, H., Sugimoto, H., Kinoshita, A., & Shimohama, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.157 · Cited by 51
Duplan, E., Sevalle, J., Viotti, J., Goiran, T., Bauer, C., Renbaum, P., Levy-Lahad, E., Gautier, C. A., Corti, O., Leroudier, N., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt003 · Cited by 45
Regulation of global gene expression and cell proliferation by APP
Wu, Y., Zhang, S., Xu, Q., Zou, H., Zhou, W., Cai, F., Li, T., & Song, W. (2016) · Scientific Reports · doi:10.1038/srep22460 · Cited by 51
Rab6 membrane association is dependent of Presenilin 1 and cellular phosphorylation events
Scheper, W., Zwart, R., & Baas, F. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.013 · Cited by 55
“In addition, g-secretase cleavage of APP is strongly inhibited in PS1 / mice, whereas a- and h-secretase cleavage are unaffected [6], supporting the hypothesis that PS1 is directly or indirectly involved in the g-secretase route of APP processing.”
BackgroundPresenilin 1 is involved in maturation and trafficking of N‐cadherin to the plasma membrane
Uemura, K., Kitagawa, N., Kohno, R., Kuzuya, A., Kageyama, T., Chonabayashi, K., Shibasaki, H., & Shimohama, S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10753 · Cited by 46
“It is involved in the processing of amyloid precursor protein (APP), producing amyloid -protein (De Strooper et al., 1998).”
BackgroundPositive and Negative Regulation of the γ-Secretase Activity by Nicastrin in a Murine Model
Li, J., Fici, G. J., Mao, C., Myers, R. L., Shuang, R., Donoho, G. P., Pauley, A. M., Himes, C. S., Qin, W., Kola, I., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301288200 · Cited by 51
Palacino, J. J., Berechid, B. E., Alexander, P., Eckman, C. B., Younkin, S. G., Nye, J. S., & Wolozin, B. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.215 · Cited by 50
The multiple paradoxes of presenilins
Checler, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00244.x · Cited by 49
“Bart De Strooper and colleagues elegantly demonstrated that the knock-out of the presenilin 1 gene led to drastic reduction in the g-secretase-mediated cleavage of bAPP (De Strooper et al. 1998).”
Background
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.